Tags: Washington University St. Louis, Bioresearch funding, Biotechnology vendor show, Washington University, WUSTL, BioResearch Product Faire, Birth Defects, Pediatric Neurology, Translational Science
Though experts may disagree on when earth’s supply of fossil fuels will be exhausted, they do agree that it will happen eventually. After all, fossil fuels typically require millions of years of degradation to create. So the race for alternative biofuels is on.
The Department of Energy (DOE) recently awarded the Washington University, St. Louis (WUSTL) $3.9 in research funding to develop bacteria that manufactures renewable biofuels. WUSTL scientists are studying Rhodococcus opacus, a bacteria that grows on toxic compounds, using them as a source of food for the production of biofuels. The goal of this research project is to produce biofuels that can completely replace petroleum-based fuels.Read More
Tags: Washington University St. Louis, Bioresearch funding, Biotechnology vendor show, Washington University, WUSTL, Renewable Energy, biofuels, laboratory equipment suppliers, NIH award, BioResearch Product Faire, Department of Energy, life scinece, life science labs, Biotechnology trade show, Reproductive Research
According to the National Cancer Institute (NCI) there are over 380,000 people living with leukemia in the United States. Each year roughly 24,500 people die from the disease and over 62,000 new cases are diagnosed. To improve treatment options for leukemia patients, the NCI recently awarded John DiPersio, MD, PhD of Washington University, St. Louis $6 million in research funding. The Professor of Medicine in Oncology at the university’s School of Medicine will use the seven years of funding to support three major areas of leukemia research in his lab. These include: improving the effectiveness of standard chemotherapy, preventing graft-versus-host disease, and developing new immunotherapies.Read More
Tags: Washington University St. Louis, Washington University, WashU, WUSTL, Leukemia, cancer research, Cancer, Research Funding, biotech vendor show, cancer research funding, Bioresearch Grant, Biotechnology trade show, NIH awards 2017, Cancer Therapeutics, Cancer Immunotherapy
The National Institute of Health (NIH) awarded Washington University in St. Louis over $1.4 million in grant funding to support their School of Medicine’s Diabetic Research Center. This award was administered through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as it has been for the last 38 years. The funding will help support the Diabetic Research Center (DRC) and their life science labs. The DRC's mission is to “support and enhance research in diabetes and related metabolic diseases” through Biomedical Research Core services as well as the Pilot and Feasibility Program.Read More
Washington University School of Medicine in St. Louis is leading an international team studying potential treatments to prevent Alzheimer’s disease. The team recently added a third medicationin this worldwide clinical trial that is already underway. According to the WU School of Medicine news site, the latest investigational drug “is designed to lower production of amyloid beta, a protein that clumps together into plaques damaging neurons in the brain, leading to memory loss, cognitive problems and confusion.”Read More
Tags: Washington University St. Louis, Washington University, WUSTL, Alzheimer' Research, Alzheimer’s, Research Funding, biotech vendor show, Alzheimer's treatment market, Bioresearch Grant, Biotechnology trade show
Despite recent advances in neuroimaging, the medical community still lacks a comprehensive map of the brain and how it changes with age. Such maps would make it possible for doctors to distinguish between what is normal aging and what is atypical, which would make it possible to link atypical changes to neurological diseases and various mental health issues. Thanks to a $34 million NIH grant, Washington University School of Medicine in St. Louis will lead a project to make such maps of the brain a reality.Read More
Determining the causes behind Alzheimer’s disease is a difficult task. Symptoms appear seemingly without provocation, and scientists have been so far unable to pinpoint a clear reason for their onset. Now bioresearchers at Washington University at St. Louis have found a possible explanation, in the form of a gene that regulates our internal clock.
One of the current trends in life science research is to find the microbes behind the processes and phenomenon with which we’re already familiar. Once we understand the role that bacteria play, we can replicate, enhance, or halt their methods as we need to. Such is the case at the Washington University at St. Louis, where bioresearchers are better understanding the microbes in our intestines in order to take a stab at obesity.
Physical adaptation is usually thought of as a very slow process. It might take a species of bird several generations to evolve a beak suited for eating fruit compared to, say, pecking wood. This change would involve the death of several birds with “incorrect” sets of genes and the survival of one type of bird with a “correct” set of genes. But what if a creature had a huge library of genes, so that they might bypass natural selection by simply expressing the right genes for their environment? That’s what researchers at Washington University at St. Louis have found occurs in the versatile fire salamander.
Nerves play a vital role in the well-being of our body. Nerve damage is among the most crippling physical damage we can sustain, which is why it is in our best interest to protect them when at all possible. So when new bioresearch from Washington University in St. Louis lays out a method to prevent the body from destroying axons, which transmit nerve signals throughout the body, it’s a sure signal of improvement in the field of nervous studies.